- Home
- DBVT vs PMM Comparison
DBVT vs PMM Comparison
Compare DBVT & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- PMM
- Stock Information
- Founded
- DBVT 2002
- PMM 1989
- Country
- DBVT France
- PMM United States
- Employees
- DBVT N/A
- PMM N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- PMM Investment Managers
- Sector
- DBVT Health Care
- PMM Finance
- Exchange
- DBVT Nasdaq
- PMM Nasdaq
- Market Cap
- DBVT 237.4M
- PMM 265.3M
- IPO Year
- DBVT N/A
- PMM N/A
- Fundamental
- Price
- DBVT $9.40
- PMM $5.87
- Analyst Decision
- DBVT Buy
- PMM
- Analyst Count
- DBVT 4
- PMM 0
- Target Price
- DBVT $14.81
- PMM N/A
- AVG Volume (30 Days)
- DBVT 41.9K
- PMM 118.3K
- Earning Date
- DBVT 07-29-2025
- PMM 01-01-0001
- Dividend Yield
- DBVT N/A
- PMM 4.68%
- EPS Growth
- DBVT N/A
- PMM N/A
- EPS
- DBVT N/A
- PMM 0.23
- Revenue
- DBVT $3,497,000.00
- PMM N/A
- Revenue This Year
- DBVT $1,700.53
- PMM N/A
- Revenue Next Year
- DBVT $535.67
- PMM N/A
- P/E Ratio
- DBVT N/A
- PMM $26.52
- Revenue Growth
- DBVT N/A
- PMM N/A
- 52 Week Low
- DBVT $2.21
- PMM $5.00
- 52 Week High
- DBVT $12.78
- PMM $6.42
- Technical
- Relative Strength Index (RSI)
- DBVT 52.73
- PMM 45.89
- Support Level
- DBVT $9.00
- PMM $5.82
- Resistance Level
- DBVT $10.12
- PMM $5.93
- Average True Range (ATR)
- DBVT 0.57
- PMM 0.04
- MACD
- DBVT 0.08
- PMM 0.00
- Stochastic Oscillator
- DBVT 72.24
- PMM 41.67
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.